Christopher Heaney

Associate Professor

Johns Hopkins University
Country flagUnited States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Background Molecular diagnostics on human fecal samples have identified a larger burden of shigellosis than previously appreciated by culture. Evidence of fold changes in immunoglobulin G (IgG) to conserved and type-specific Shigella antigens could be used to validate the molecular assignment of type-specific Shigella as the etiology of acute diarrhea and support polymerase chain reaction (PCR)–based microbiologic end points for vaccine trials. Methods We will test dried blood spots collected at enrollment and 4 weeks later using bead-based immunoassays for IgG to invasion plasmid antigen B and type-specific lipopolysaccharide O-antigen for Shigella flexneri 1b, 2a, 3a, and 6 and Shigella sonnei in Shigella-positive cases and age-, site-, and season-matched test-negative controls from all sites in the Enterics for Global Health (EFGH) Shigella surveillance study. Fold antibody responses will be compared between culture-positive, culture-negative but PCR-attributable, and PCR-positive but not attributable cases and test-negative controls. Age- and site-specific seroprevalence distributions will be identified, and the association between baseline antibodies and Shigella attribution will be estimated. Conclusions The integration of these assays into the EFGH study will help support PCR-based attribution of acute diarrhea to type-specific Shigella, describe the baseline seroprevalence of conserved and type-specific Shigella antibodies, and support correlates of protection for immunity to Shigella diarrhea. These insights can help support the development and evaluation of Shigella vaccine candidates.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (16)

Robert Breiman

Professor

Emory University

UNITED STATES
View details

Annukka Antar

Assistant Professor of Medicine

Johns Hopkins University School of Medicine

UNITED STATES
View details

Ivan Spasojevic

Duke University

UNITED STATES
View details

Olivia Aspiras

Research Associate

Michigan State University

UNITED STATES
View details

Sophia Tan

Stanford University

UNITED STATES
View details

Andrew Azman

Associate Professor

University of Geneva

SWITZERLAND
View details

Zoe Demko

Johns Hopkins University School of Medicine

UNITED STATES
View details

Nora Pisanic

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES
View details

Maria Deloria Knoll

Resesarch Professor; Director of Epidemiology, IVAC

Johns Hopkins University Bloomberg School of Public Health

UNITED STATES
View details

Felipe Andrade

Johns Hopkins University School of Medicine

UNITED STATES
View details

Nicholas J. Mantis

Chief, Laboratory of Microbial Pathogenesis and Immunology

University at Albany, State University of New York

UNITED STATES
View details

Xueyan Zhang

University of Pittsburgh

UNITED STATES
View details

Nicole Jones

Assistant Professor

Michigan State University College of Human Medicine

UNITED STATES
View details

Russell Dickerson

University of Maryland

UNITED STATES
View details

Dr. Mohammad Tahir Yousafzai

Associate Professor

University of New South Wales

AUSTRALIA
View details

James A Platts-Mills

University of Virginia

UNITED STATES
View details